Related Experiment Video

Updated: Jun 22, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Tylophorine arrests carcinoma cells at G1 phase by downregulating cyclin A2 expression

Chia-Mao Wu1, Cheng-Wei Yang, Yue-Zhi Lee

  • 1Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 350, Taiwan, ROC.

Biochemical and Biophysical Research Communications
|June 9, 2009
PubMed

Insights

Tylophorine, a plant alkaloid, halts cancer cell growth by arresting them in the G1 phase. This occurs due to decreased cyclin A2 expression, a key finding for understanding its anti-cancer effects.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Tylophorine, derived from Tylophora indica, shows anti-inflammatory and anti-cancer properties.
  • The precise anti-cancer mechanisms and cell cycle effects of tylophorine are not fully understood.

Purpose of the Study:

  • To elucidate the anti-cancer mechanisms of tylophorine.
  • To investigate the effects of tylophorine on the cell cycle progression of carcinoma cells.

Main Methods:

  • Utilized asynchronizing and synchronizing cell cycle approaches.
  • Analyzed cell cycle progression in HepG2, HONE-1, and NUGC-3 carcinoma cells.
  • Assessed the expression levels of cyclin A2.

Main Results:

  • Tylophorine treatment significantly retards S-phase progression.
  • Tylophorine induces a dominant G1 phase arrest in carcinoma cells.
  • Tylophorine downregulates cyclin A2 expression; overexpression of cyclin A2 rescues the G1 arrest.

Conclusions:

  • Tylophorine exhibits anti-cancer activity by arresting cells in the G1 phase.
  • Downregulation of cyclin A2 is identified as a critical mechanism underlying tylophorine-induced G1 arrest.
  • This study provides novel insights into tylophorine's anti-cancer effects at the molecular level.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.